Diagnosis of Lyme Borreliosis
By M. Aguero-Rosenfeld, Guiqing Wang, I. Schwartz, G. Wormser. Clinical Microbiology Reviews, 2005
725 citations recorded by the source corpus.
Subfields: Infectious Diseases, Parasitology
View Paper: https://www.semanticscholar.org/paper/5f17ca6d88170ac4aa2867e4ef998a89f62e946f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Å. Mygland
- F. Strle
- E. Baron
- U. Ljøstad
- J. Miller
- M. Weinstein
- S. Richter
- P. Gilligan
Citations in the corpus
- A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a (2013, background): “Patients with a diagnosis of Lyme disease have demonstrated immunoserologic evidence of coinfection with Babesia microti, Anaplasma phagocytophilum or Erlichia species; in Europe; coinfection with tick-borne encephalitis virus should also be considered [221].”
- The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. (2006, neutral): “burgdorferi DNA in CSF using PCR by a laboratory with excellent quality control can also be useful [103, 124, 167], but few laboratories are capable of accurately performing this test.”
- Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. (2011, background): “Serology is usually the first and often the only supporting diagnostic measure to be deployed, because it is relatively easy to obtain samples, laboratory testing facilities are widely accessible, and the tests, despite publicised difficulties and controversy, now show acceptable sensitivity and spe”
- EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis (2010, methodology): “Analytic specificity of PCR (the ability to identify exclusively Bb DNA rather than similar DNA) is 98–100% provided precautions are taken to avoid contaminations, and amplified products are specified by an appropriate method, for example sequencing [ 1 ,33,35,39].”